scholarly journals The relationship of HLA class I and II phenotypes to clinical features of Behcet's disease.

1990 ◽  
Vol 13 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Kazuyuki Morita ◽  
Junko Moriuchi ◽  
Yukinobu Ichikawa ◽  
Kimiyoshi Tsuji ◽  
Shigeru Arimori
Keyword(s):  
Clinical Features ◽  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Hla Class I ◽  
Class I ◽  
Behcet's Disease ◽  
Relationship Of ◽  
The Relationship

HLA Class I in Egyptian patients with Behçet’s disease: new association with susceptibility, protection, presentation and severity of manifestations

2018 ◽  
Vol 48 (2) ◽  
pp. 121-129 ◽  
Author(s):  
Mohanad M. Elfishawi ◽  
Fatema Elgengehy ◽  
Ghada Mossallam ◽  
Sally Elfishawi ◽  
Mostafa Alfishawy ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Hla Class I ◽  
Class I ◽  
Behcet's Disease ◽  
Egyptian Patients ◽  
New Association

AB0009 The HLA Class I Region in Behçet's Disease: Identifying the Most Relevant Amino Acid Positions

2015 ◽  
Vol 74 (Suppl 2) ◽  
pp. 894.1-894
Author(s):  
L. Ortiz-Fernández ◽  
F.D. Carmona ◽  
M.-A. Montes-Cano ◽  
J.-R. García-Lozano ◽  
M. Conde-Jaldόn ◽  
...  
Keyword(s):  
Amino Acid ◽  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Hla Class I ◽  
Class I ◽  
Behcet's Disease ◽  
Class I Region

New insights of HLA class I association to Behçet’s disease in Portuguese patients

2008 ◽  
Vol 72 (4) ◽  
pp. 379-382 ◽  
Author(s):  
A. Bettencourt ◽  
C. Pereira ◽  
L. Carvalho ◽  
C. Carvalho ◽  
J. V. Patto ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Hla Class I ◽  
Class I ◽  
Behcet's Disease

MIC-A allele profiles and HLA class I associations in Behçet's disease

1999 ◽  
Vol 49 (7-8) ◽  
pp. 613-617 ◽  
Author(s):  
Graham R. Wallace ◽  
David H. Verity ◽  
Lisa J. Delamaine ◽  
Shigeaki Ohno ◽  
Hidetoshi Inoko ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Hla Class I ◽  
Class I ◽  
Behcet's Disease

HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behçet’s disease

2001 ◽  
Vol 57 (5) ◽  
pp. 457-462 ◽  
Author(s):  
N. Mizuki ◽  
M. Ota ◽  
Y. Katsuyama ◽  
K. Yabuki ◽  
H. Ando ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Hla Class I ◽  
Class I ◽  
Behcet's Disease ◽  
Iranian Patients

scholarly journals Vasculitis damage index in Behçet’s disease

2021 ◽  
Vol 61 (1) ◽  
Author(s):  
Fatema T. Elgengehy ◽  
Sherif M. Gamal ◽  
Nesreen Sobhy ◽  
Ibrahem Siam ◽  
Ahmed M. Soliman ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Immunosuppressive Treatment ◽  
Damage Index ◽  
Clinical Manifestations ◽  
Behcet's Disease ◽  
Vasculitis Damage Index ◽  
Relationship Of ◽  
The Relationship

Abstract Background Vasculitis damage index (VDI) is a validated damage index for systemic vasculitis, and as Behçet’s disease is considered one of systemic vascular disease we aimed to study the relationship of the vasculitis damage index to clinical manifestations and comorbidity in patients with Behçet’s disease (BD) to determine if VDI could be used to assess damage in patients with BD. Methods A total of 109 patients with BD were recruited from the Rheumatology Department (outpatient and inpatient clinic), Cairo University Hospitals. All patients were subjected to full history taking, clinical examination, and routine laboratory investigations. Disease activity was assessed by the BD current activity form, and the VDI was calculated in all patients. The relationship of the VDI to the disease clinical manifestations was studied. Mann–Whitney and Kruskal Wallis tests were used to estimate differences in quantitative variables. Spearman correlation test was used to test for correlation between quantitative variables. Results In the current study, the VDI ranged from 1 to 10, with a mean of 3.5 ± 1.8. It was significantly associated with total thrombosis (P = 0.022); total neurological manifestations (P = 0.000), especially stroke and cranial nerve affection; uveitis (P = 0.005); avascular necrosis (AVN) (P = 0.015); osteoporosis (P = 0.01); impaired vision (P < 0.0001); cataract (P < 0.0001); and diabetes (P = 0.012). Generally, immunosuppressive treatment was significantly associated with VDI (P = 0.039), especially cyclophosphamide (P < 0.0001), biological agent (P = 0.008), chlorambucil (P = 0.003), and anticoagulant (P = 0.02). VDI was also significantly correlated with age (P = 0.033), disease duration (P = 0.029), and duration of eye involvement (P = 0.003). Conclusion VDI is significantly associated with most disease parameters of BD, except for parameters such as mucocutaneous manifestations and uncomplicated venous thrombosis; however, further studies may be needed to establish BD-specific damage index.

scholarly journals The relationship of pentraxin-3 levels with IL-17, fetuin-A, insulin in patients with Behçet's disease

2017 ◽  
Vol 35 (4) ◽  
pp. 195-200
Author(s):  
Sinem Sag ◽  
Ayhan Kamanlı ◽  
Mustafa Altındis ◽  
Mustafa Serdar Sag ◽  
Halil Harman ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Pentraxin 3 ◽  
Fetuin A ◽  
Behcet's Disease ◽  
Relationship Of ◽  
The Relationship
Sign in / Sign up

Export Citation Format

Share Document